The newly combined company will operate under the name Firefly Neuroscience and be headquartered in Toronto. Following closing, Firefly, which is currently private, will trade on the Nasdaq Capital Market.
Firefly will continue to accelerate the development and commercialization of its artificial intelligence-driven Brain Network Analytics platform. The technology, which has already completed the rigorous FDA approval process, uses artificial intelligence to help front-line clinicians better measure brain function and drug developers to create more effective treatments for mental illnesses and cognitive disorders.
“Firefly is a forward-thinking company with a clear growth strategy,” said Rick Werner, co-chair of Haynes Boone’s Capital Markets and Securities Practice Group. “This new merger positions them to benefit as an AI-enabled, commercial-stage technology company traded on the Nasdaq Capital Market. We thank them for their trust in us to help complete this merger.”
Along with Werner, the Haynes Boone deal team included partners Simin Sun, Alla Digilova and Jeff Wolfson along with associates Brent Duddles, Thomas Carroll and Dan Collins and Counsel Ed Lebow.
The all-stock deal is expected to close in the first quarter of 2024.
About Haynes Boone
Founded in 1970, Haynes and Boone, LLP provides a full spectrum of legal services across multiple sectors, including energy, financial services, private equity and technology. The firm’s nearly 700 lawyers practice in 19 offices in California, Colorado, Illinois, New York, North Carolina, Texas, Virginia and Washington, D.C., as well as London, Mexico City and Shanghai. Haynes Boone was recognized in the 2022 BTI Consulting Group’s A-Team report, which identified firms commended by in-house counsel for superior client service, and it was ranked 21st in The American Lawyer’s 2023 Diversity Scorecard, which evaluated 228 participating firms by the diversity of their attorney populations. For more information, visit haynesboone.com.